Intrathecal Double Checkpoint Inhibition

Clinical trial NCT05598853 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05598853
Sponsor: University of Zurich
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leptomeningeal Metastasis Non-small Cell Lung Cancer Stage IV Melanoma Stage IV

Start date: 2022-11-25
Primary completion: 2025-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.